000 01893 a2200565 4500
005 20250518061538.0
264 0 _c20200312
008 202003s 0 0 eng d
022 _a1437-7772
024 7 _a10.1007/s10147-019-01539-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNakanishi, Yu
245 0 0 _aAlbumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer.
_h[electronic resource]
260 _bInternational journal of clinical oncology
_cJan 2020
300 _a74-81 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Agents, Immunological
_xtherapeutic use
650 0 4 _aBiomarkers, Tumor
_xblood
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xblood
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPrognosis
650 0 4 _aProgrammed Cell Death 1 Receptor
_xagonists
650 0 4 _aRetrospective Studies
650 0 4 _aSerum Albumin
_xanalysis
650 0 4 _aSerum Globulins
_xanalysis
650 0 4 _aSurvival Analysis
700 1 _aMasuda, Takeshi
700 1 _aYamaguchi, Kakuhiro
700 1 _aSakamoto, Shinjiro
700 1 _aHorimasu, Yasushi
700 1 _aMimae, Takahiro
700 1 _aNakashima, Taku
700 1 _aMiyamoto, Shintaro
700 1 _aTsutani, Yasuhiro
700 1 _aIwamoto, Hiroshi
700 1 _aFujitaka, Kazunori
700 1 _aMiyata, Yoshihiro
700 1 _aHamada, Hironobu
700 1 _aOkada, Morihito
700 1 _aHattori, Noboru
773 0 _tInternational journal of clinical oncology
_gvol. 25
_gno. 1
_gp. 74-81
856 4 0 _uhttps://doi.org/10.1007/s10147-019-01539-2
_zAvailable from publisher's website
999 _c30122549
_d30122549